[Saccharomyces cerevisiae vaginitis].
García-Martos
P
P
Hernández
J M
JM
Mira
J
J
Galán
F
F
Marín
P
P
D000328:Adult; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000627:therapeutic use; D002181:Candidiasis, Vulvovaginal / Q000175:diagnosis; D003937:Diagnosis, Differential; D004198:Disease Susceptibility; D005260:Female; D006801:Humans; D009181:Mycoses / Q000175:diagnosis / Q000382:microbiology*; D012008:Recurrence; D012441:Saccharomyces cerevisiae / Q000302:isolation & purification* / Q000472:pathogenicity; D015163:Superinfection / Q000382:microbiology*; D014552:Urinary Tract Infections / Q000150:complications / Q000188:drug therapy; D014627:Vaginitis / Q000382:microbiology*
D000900:Anti-Bacterial Agents